
SPLASH
NCT04647526
JCP097
Study Evaluating mCRPC Treatment Using PSMA [Lu-177]-PNT2002 Therapy After Second-line Hormonal Treatment (SPLASH)
Status:
Recruiting

III
Phase

3rd
Line of Therapy

Advanced / Metastatic
Disease Stage

Biomarker(s)
Investigational
Product
[Lu-177]-PNT2002
Treatment Arms
o Experimental: [Lu-177]-PNT2002 (Arm A)
o Active Comparator:
Control Arm (Arm B)